ONCY Oncolytics Biotech Inc.
Healthcare$0.81+0.00%OpenMarket Cap: $81.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-24.46
P/S
0.00
EV/EBITDA
-3.39
DCF Value
$0.02
FCF Yield
-25.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
5132.0%
ROA
-428.4%
ROIC
-1067.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-9.3M | $-12.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-2.2M | $-1.5M | $— | — |
| FY null | $0.00 | NaN% | $-39.4M | $-39.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-13.8M | $-14.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-5.7M | $-6.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-7.0M | $-6.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-8.4M | $-8.0M | $— | — |
| FY null | $0.00 | NaN% | $-35.0M | $-31.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-9.9M | $-9.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-5.8M | $-5.3M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-8.7M | $-6.9M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-8.8M | $-3.9M | $-0.05 | — |